Research and product development for Crimean–Congo haemorrhagic fever: priorities for 2024–30
Yazarlar (1)
Prof. Dr. Zati VATANSEVER Kafkas Üniversitesi, Türkiye
| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | Lancet Infectious Diseases (Q1) | ||
| Dergi ISSN | 1473-3099 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 04-2025 |
| Cilt / Sayı / Sayfa | 25 / 4 / – | DOI | 10.1016/S1473-3099(24)00656-X |
| Makale Linki | https://doi.org/10.1016/s1473-3099(24)00656-x | ||
| Özet |
| Crimean–Congo haemorrhagic fever (CCHF) is a widely distributed and potentially fatal tick-borne viral disease with no licensed specific treatments or vaccines. In 2019, WHO published an advanced draft of a research and development roadmap for CCHF that prioritised the development and deployment of the medical countermeasures most needed by CCHF-affected countries. This Personal View presents updated CCHF research and development priorities and is the product of broad consultation with a working group of 20 leading experts in 2023–24. The strategic goals, milestones, and timelines have been revised and expanded to reflect scientific advances since 2019, including the identification of antibodies with therapeutic potential and the progression of four vaccine candidates through phase 1 clinical trials. This update emphasises the need for a One Health approach to manage CCHF, from integrated … |
| Anahtar Kelimeler |
Science Direct
Research and product development for Crimean–Congo haemorrhagic fever: priorities for 2024–30
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları | |
| WoS | 11 |
| SCOPUS | 12 |
| Google Scholar | 14 |